?

Thompson Jeffery S

Director
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK 1510398

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
31,575
Price per Share :
$16.19
Equivalence :
$511,199.25

Transaction History

  • A
    Form 4
    31,575 Shares After Transaction
    Value : $n/a
    $0.0
    06/14/23
  • Footnotes:
    #1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024.